Sign inJoin waitlistJoin the waitlist

Michael Serzan

Physician · Dana-Farber Cancer Institute

Credentials: · · · · ·

History

Dana-Farber Cancer Institute
2023–Present

Georgetown Lombardi Comprehensive Cancer Center
2018–2020
MedStar Georgetown University Hospital
2015–2018
Robert Wood Johnson Medical School
2011–2015
Boston College
2007–2011

Research

Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma
Journal of Cancer Metastasis and Treatment · 2021 · First of 2 authors · 35 citations
Takotsubo Cardiomyopathy Associated With Checkpoint Inhibitor Therapy: Endomyocardial Biopsy Provides Pathological Insights to Dual Diseases
Review · JACC CardioOncology · 2021 · First of 5 authors · Corresponding · 31 citations
The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids
Journal of the National Comprehensive Cancer Network · 2022 · 29 citations

Michael Atkins
8 papers
Andrew Ip
3 papers
Andrew Pecora
3 papers
Bradley McGregor
3 papers
NS
Neil Shah
3 papers
Stephanie Berg
3 papers
Toni Choueiri
3 papers
Wenxin Xu
3 papers
Aishwarya Sridhar
2 papers · 1 as a resident
HE
Hamid Emamekhoo
2 papers
HM
Hassan Murad
2 papers
Irbaz Riaz
2 papers · 2 as a fellow